medical Class II Updated 2019-01-09

ORTHO-CLINICAL DIAGNOSTICS recalls VITROS NT-proBNP Reagent, Cat No. 6802156 Product Usage:

Recalled Product

VITROS NT-proBNP Reagent, Cat No. 6802156 Product Usage: For in vitro diagnostic use only. For the quantitative measurement of N-terminal pro Brain Natriuretic Peptide (NT-proBNP) in human serum and plasma (EDTA or heparin) using the VITROS ECi/ECiQ Immunodiagnostic Systems, the VITROS 3600 Immunodiagnostic System and the VITROS 5600 Integrated System to aid in the diagnosis of congestive heart failure and for the risk stratification of acute coronary syndrome and congestive heart failure. The test is further indicated as an aid in the assessment of increased risk of cardiovascular events and mortality in patients at risk for heart failure who have stable coronary artery disease. The test can also be used in the assessment of heart failure severity in patients diagnosed with congestive heart failure.


Hazard / Issue

The firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin concentrations which are lower than indicated in the current Instructions for Use.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: All expired, in-date, and future lots released.
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →